Search Results

Kenakin during the 4 weeks, scheduled according to the professor's availability.

December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was

October 2022 Keratinocyte-derived defensins activate neutrophil-specific receptors Mrgpra2a/b to prevent We generated mutant mouse lines lacking the entire Defensin (Def) gene cluster in keratinocytes or Mrgpra2a

August 2022 G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions The kinase GRK2 and the multifunctional scaffolding protein β-arrestin2 are key integrated signaling

Kevin Pfleger Dr. GPCR Podcast << Back to podcast list Dr. Kevin Pfleger About this episode Dr. I sat down with Kevin to chat about GPCRs, pharmacology, and his contributions to the field in both the Kevin is also Director, Biomedical Innovation at The University of Western Australia (UWA) and the MTPConnect Join me and learn more about Kevin’s work and how he manages all his responsibilities. Dr. Kevin Pfleger on the web LinkedIn ResearchGate Pubmed Google Scholar University of Western Australia

Terry Kenakin Dr. GPCR Podcast << Back to podcast list Dr. Terry Kenakin About Dr. Terry Kenakin After obtaining a BSc in chemistry at the University of Alberta Edmonton Canada, Terry Kenakin then moved to the UK, where he did a post-doctoral fellowship in University College London with Kenakin joined Glaxo Inc in RTP where he remained for 25 years through iterations of Glaxo Inc, GlaxoWellcome Terry Kenakin on the web LinkedIn UNC Department of Pharmacology Amazon ResearchGate Pubmed . Dr.

Kenneth A. Jacobson Dr. GPCR Podcast << Back to podcast list Dr. Kenneth A. Jacobson About Dr. Kenneth A. Jacobson Kenneth A. Kenneth A. Jacobson on the web NIDDK Web of Science Google Scholar LinkedIn Twitter Dr.